会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • A PROCESS FOR PREPARATION OF BIOAVAILABLE WHITE CURCUMIN - A UNIQUE BLEND OF HYDROGENATED CURCUMINOIDS
    • 一种制备可生物降解的白矾石的方法 - 加氢的UR O A A UE IDS IDS
    • WO2016097914A1
    • 2016-06-23
    • PCT/IB2015/059348
    • 2015-12-04
    • AUREA BIOLABS PRIVATE LIMITED
    • GOPI, SreerajJACOB, JobyGEORGE, Robin
    • A61K31/045A61K31/05C07C57/42C07C57/72C07C209/26
    • A61K31/121A23L33/105A23V2002/00A61K47/6951C07C41/20C07C45/62C08B37/0015C07C43/23C07C49/225
    • The present invention discloses a process for preparation of white curcumin from purified curcuminoids. The curcuminoids are obtained by solvent extraction and crystallization of dried turmeric powder. The autoclave is charged with ethyl acetate and the 95% purity curcuminoids mixture is added to and stirred for uniformity at room temperature. 5% (w/w) of 10% palladium carbon is added to the reaction mixture and allowed for hydrogenation in the presence of hydrogen gas at 2 lbps pressure and stirred continuously for 15 hours. Once the reaction is completed, the reaction mixture is filtered and washed with ethyl acetate. The ethyl acetate is distilled off and crude mass is stirred with water to obtain a solid precipitate. Finally, the solid obtained is filtered and dried to pale brown crystals of white curcumin. White curcumin is encapsulated with beta- cyclodextrin, which exhibited increased bioavailability. White curcumin also exhibited anti-oxidant and chemopreventive activities.
    • 本发明公开了一种从纯化姜黄素制备白姜黄素的方法。 姜黄素通过溶剂萃取和结晶的姜黄粉得到。 向高压釜中加入乙酸乙酯,并将95%纯度的姜黄色调混合物加入并在室温下搅拌均匀。 将5%(w / w)的10%钯碳加入到反应混合物中,并在氢气存在下以2l / s压力进行氢化并连续搅拌15小时。 一旦反应完成,将反应混合物过滤并用乙酸乙酯洗涤。 蒸馏除去乙酸乙酯,将粗物质与水一起搅拌,得到固体沉淀物。 最后,将得到的固体过滤并干燥成白色姜黄素的淡棕色晶体。 白色姜黄素用β-环糊精包封,其呈现出增加的生物利用度。 白姜黄素还具有抗氧化和化学预防作用。
    • 7. 发明申请
    • MALONIC ACID DI-SALTS AND A METHOD FOR PREPARING MALONYL DIHALIDES
    • 马来酸钠盐和一种制备马来酸酐的方法
    • WO2013090547A1
    • 2013-06-20
    • PCT/US2012/069468
    • 2012-12-13
    • E. I. DU PONT DE NEMOURS AND COMPANY
    • ZHANG, WenmingANNIS, Gary David
    • C07C257/06C07D487/04C07C57/34C07C51/60C07C57/72
    • C07D471/04C07C51/60C07C55/36C07C57/34C07C57/36C07D213/55C07C57/72
    • A compound of Formula (2) is disclosed: wherein R 1 , M A and M B are as defined in the disclosure. Also disclosed is a method for preparing a compound of Formula (1): wherein R 1 and X are as defined in the disclosure comprising contacting a compound of Formula (2) with a halogenating agent. Also disclosed is a method for preparing a compound of Formula (4): wherein R 1 , R 3 and R 4 are as defined in the disclosure, comprising reacting a compound of Formula (5): wherein R 3 and R 4 are as defined in the disclosure with a compound of Formula (1), with a compound of Formula (1), the process of preparing the compound of Formula (4) includes the step of preparing the compound of Formula (1) from the compound of Formula (2) by the method disclosed above. Also disclosed is compound that is methyl 3,5-dichlorobenzeneethanimidate methyl 3,5 dichlorobenzeneethanimidate or ethyl 3,5 dichlorobenzeneethanimidate or salts thereof.
    • 公开了式(2)的化合物:其中R1,MA和MB如本公开所定义。 还公开了制备式(1)化合物的方法:其中R 1和X如本公开所定义,包括使式(2)的化合物与卤化剂接触。 还公开了制备式(4)化合物的方法:其中R 1,R 3和R 4如本公开内容所定义,包括使式(5)化合物:其中R 3和R 4如本公开所定义的化合物与 式(1)的化合物与式(1)的化合物的制备方法包括由式(2)的化合物通过方法制备式(1)的化合物的步骤 如上所述。 还公开了3,5-二氯苯甲酰亚胺酸甲酯,3,5-二氯苯甲酰亚胺酸甲酯或3,5-二氯苯甲酰亚氨酸乙酯或其盐的化合物。